FDA Rejects Regeneron’s Bid to Extend EYLEA HD Dosing Beyond 16 Weeks
April 22, 2025

FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval

Regeneron’s proposal to lengthen EYLEA HD dosing intervals to 24 weeks hits a CRL roadblock.​ The wait for extended treatment…

Thumbnail Article_Article 3
April 5, 2025

Key Retinal Debates Sizzle in APAO-AIOC 2025 India AAO Symposium

Experts grappled with contemporary retinal topics from firstline treatments in PDR, CSC and myopic tractional maculopathy to OCT-A. The sun…

latest posts
The,Sun's,Rays,Over,The,Sea.
February 24, 2022

A Ray of Hope in Retinal Degeneration

Panic,Cat,Scare,Of,Injection,Syringe,Or,Vaccine.,Risk,Of
February 7, 2022

After a Shot to the Eye: Patient-Reported “Issues” after Intravitreal Injection

Female,Hand,Holds,Black,Binoculars,On,A,Yellow,Background.,Journey,
February 18, 2021

RETINAWESOME 007: Searching for the Next Challenge in Retina Surgery

Global business concept. Group of various ethnic businessperson. Diversity.
November 25, 2020

Talking Leadership, Innovation, and Management with Samsara Vision’s Tom Ruggia

Businesswoman Stands On Long Road With Road Map Painted On It
September 24, 2020

Mapping the Road Ahead: Stem Cell Therapy in Diabetic Retinopathy

iStock 974812572
February 20, 2020

The Role of JNK Pathway in Retinal Degeneration and Vision Loss

Discover our fascinating content at issuu

explore